Stock listing

Aim Immunotech Inc.

Selected listing: A2PREX · LS · EUR · DE

Aim Immunotech Inc. (Lang & Schwarz: A2PREX), Health Technology. Latest release Sep 3, 2026: AIM ImmunoTech Significantly Expands Ampligen Global Patent…

A2PREX:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A2PREX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Aim Immunotech Inc.

AIM ImmunoTech Significantly Expands Ampligen Global Patent Estate with Long COVID Protection across Europe and the United Kingdom Through 2041

September 3, 2026

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen(R) Toward Planned Phase 3 Development in Pancreatic Cancer

August 11, 2026

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

August 10, 2026

AIM ImmunoTech : Ahead of Schedule on 'Last Dose' DURIPANC Critical Clinical Inflection Point

August 3, 2026

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

July 7, 2026

All Aim Immunotech Inc. news →

Events

Replays

AIM ImmunoTech Inc. (AIM) Q2 2025 Earnings Call
Wed, Aug 20, 2025 · 02:40 PM ET
Watch
AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call
Tue, Apr 01, 2025 · 08:30 AM ET
Watch
AIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call
Fri, Nov 15, 2024 · 08:30 AM ET
Watch

Research Aim Immunotech Inc.

Aim Immunotech Inc. company profile

View the public company page for Aim Immunotech Inc. on 6ix.

Aim Immunotech Inc. news

Read company news and market updates connected to Aim Immunotech Inc..

Aim Immunotech Inc. investor events

Find investor webinars, events, and replay context for Aim Immunotech Inc..